Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential

Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

→ top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad)

Should you invest $1,000 in Denali Therapeutics right now?

Before you consider Denali Therapeutics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Denali Therapeutics wasn't on the list.

While Denali Therapeutics currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Companies Mentioned in This Article

Company	MarketRank™	Current Price	Price Change	Dividend Yield	P/E Ratio	Consensus Rating	Consensus Price Target
Denali Therapeutics (DNLI)	3.66 of 5 stars	$15.56	-3.4%	N/A	-14.41	Buy	$41.22
Ultragenyx Pharmaceutical (RARE)	4.4289 of 5 stars	$44.28	-1.8%	N/A	-5.32	Moderate Buy	$88.08
Sarepta Therapeutics (SRPT)	4.8756 of 5 stars	$124.25	+6.1%	N/A	-20.30	Moderate Buy	$158.38
Pfizer (PFE)	4.995 of 5 stars	$26.26	-0.2%	6.40%	72.94	Hold	$36.33
Exelixis (EXEL)	4.9776 of 5 stars	$23.71	+1.8%	N/A	37.05	Moderate Buy	$26.29
Moderna (MRNA)	3.9621 of 5 stars	$108.85	+0.9%	N/A	-8.77	Hold	$126.49
United Therapeutics (UTHR)	4.4104 of 5 stars	$237.00	+1.1%	N/A	11.95	Moderate Buy	$294.25
Biogen (BIIB)	4.9304 of 5 stars	$201.99	+4.6%	N/A	25.31	Moderate Buy	$295.35
Sanofi (SNY)	3.0639 of 5 stars	$46.61	-2.3%	2.96%	19.75	Hold	$55.00
Eli Lilly and Company (LLY)	4.8418 of 5 stars	$732.20	-1.8%	0.71%	126.24	Moderate Buy	$728.05